温州医科大学学报
溫州醫科大學學報
온주의과대학학보
Journal of Wenzhou Medical University
2015年
2期
79-84
,共6页
李德周%段志良%郭江龙%王思娜%刘慧芳%王志斌%钟晓芝%陈永平%金生
李德週%段誌良%郭江龍%王思娜%劉慧芳%王誌斌%鐘曉芝%陳永平%金生
리덕주%단지량%곽강룡%왕사나%류혜방%왕지빈%종효지%진영평%금생
丙型肝炎病毒%细胞毒性T细胞%表位%DNA疫苗%小鼠
丙型肝炎病毒%細胞毒性T細胞%錶位%DNA疫苗%小鼠
병형간염병독%세포독성T세포%표위%DNA역묘%소서
hepatitis C virus%cytotoxicity T lymphocyte%epitope%DNA vaccine%mice
目的:构建丙型肝炎病毒(HCV)CTL-Th表位嵌合DNA疫苗并探讨其体内免疫学效应。方法:基于我们前期从HCV中鉴定的4条HLA-A*0201限制性CTL(细胞毒性T细胞)表位(NS4b78-86、NS5a367-375、C181-189和NS2172-180),2条HLA-A*1101限制性CTL表位(NS3609-617和NS5b251-259),1条HLA-A*2402限制性CTL表位(NS5b382-390)和2条Th(辅助性T细胞)表位(P73-15和NS5A276-288),合成编码串联CTL表位和Th表位的基因并克隆入真核表达质粒pcDNATM3.1/myc-His(-)A;阳性重组质粒分别免疫HLA-A*0201、HLA-A*1101和HLA-A*2402转基因小鼠,采用ELISPOT实验和CTL杀伤实验检测小鼠脾细胞内单个CTL表位特异性T细胞的水平及其杀伤靶细胞的效应。结果:合成了含有Kozak序列和编码Igκ信号链序列、7条CTL表位、2条Th表位的基因序列并顺利克隆入了真核表达质粒。阳性重组质粒免疫三种转基因小鼠后,采用ELISPOT实验检测到小鼠脾细胞内存在单个CTL表位特异性分泌IFN-γ的CTL,后者可杀伤负载单个CTL表位的脾细胞。结论:成功构建了可诱导CTL反应的HCV的CTL-Th表位嵌合DNA疫苗。
目的:構建丙型肝炎病毒(HCV)CTL-Th錶位嵌閤DNA疫苗併探討其體內免疫學效應。方法:基于我們前期從HCV中鑒定的4條HLA-A*0201限製性CTL(細胞毒性T細胞)錶位(NS4b78-86、NS5a367-375、C181-189和NS2172-180),2條HLA-A*1101限製性CTL錶位(NS3609-617和NS5b251-259),1條HLA-A*2402限製性CTL錶位(NS5b382-390)和2條Th(輔助性T細胞)錶位(P73-15和NS5A276-288),閤成編碼串聯CTL錶位和Th錶位的基因併剋隆入真覈錶達質粒pcDNATM3.1/myc-His(-)A;暘性重組質粒分彆免疫HLA-A*0201、HLA-A*1101和HLA-A*2402轉基因小鼠,採用ELISPOT實驗和CTL殺傷實驗檢測小鼠脾細胞內單箇CTL錶位特異性T細胞的水平及其殺傷靶細胞的效應。結果:閤成瞭含有Kozak序列和編碼Igκ信號鏈序列、7條CTL錶位、2條Th錶位的基因序列併順利剋隆入瞭真覈錶達質粒。暘性重組質粒免疫三種轉基因小鼠後,採用ELISPOT實驗檢測到小鼠脾細胞內存在單箇CTL錶位特異性分泌IFN-γ的CTL,後者可殺傷負載單箇CTL錶位的脾細胞。結論:成功構建瞭可誘導CTL反應的HCV的CTL-Th錶位嵌閤DNA疫苗。
목적:구건병형간염병독(HCV)CTL-Th표위감합DNA역묘병탐토기체내면역학효응。방법:기우아문전기종HCV중감정적4조HLA-A*0201한제성CTL(세포독성T세포)표위(NS4b78-86、NS5a367-375、C181-189화NS2172-180),2조HLA-A*1101한제성CTL표위(NS3609-617화NS5b251-259),1조HLA-A*2402한제성CTL표위(NS5b382-390)화2조Th(보조성T세포)표위(P73-15화NS5A276-288),합성편마천련CTL표위화Th표위적기인병극륭입진핵표체질립pcDNATM3.1/myc-His(-)A;양성중조질립분별면역HLA-A*0201、HLA-A*1101화HLA-A*2402전기인소서,채용ELISPOT실험화CTL살상실험검측소서비세포내단개CTL표위특이성T세포적수평급기살상파세포적효응。결과:합성료함유Kozak서렬화편마Igκ신호련서렬、7조CTL표위、2조Th표위적기인서렬병순리극륭입료진핵표체질립。양성중조질립면역삼충전기인소서후,채용ELISPOT실험검측도소서비세포내존재단개CTL표위특이성분비IFN-γ적CTL,후자가살상부재단개CTL표위적비세포。결론:성공구건료가유도CTL반응적HCV적CTL-Th표위감합DNA역묘。
Objective: To construct hepatitis C virus (HCV) CTL-Th epitopes chimeric DNA vaccine and explore its in vivo immune response. Methods:Based on previously identified four HCV-specific HLA-A*0201-restricted CTL (Cytotoxic T Lymphocyte) epitopes (NS4b_78, NS5a_367, C_181 and NS2_172), two HLA-A*1101-restricted CTL epitopes (NS3_609 and NS5b_251), one HLA-A*2402-restricted CTL epitopes (NS5b_382) and two Th epitopes (P73-15 and NS5A276-288), the gene encoding chimeric CTL epitopes and Th epit-opes was synthesized and cloned into eukaryotic expressing vector pcDNATM3.1/myc-His(-) A. The recombinant plasmid was used to immunize HLA-A*0201, HLA-A*1101 and HLA-A*2402 transgenic mice, ELISPOT and CTL cytotoxicity assay were used to measure the frequencies of CTL epitope-speciifc T cells in splenocytes of mice and the cytotoxic activity of CTL against target cells. Results:The gene containing Kozak sequence and en-coding Igκchain signal sequence, seven CTL epitopes, two Th epitopes was successfully cloned into eukaryotic expressing vector. Recombinant plasmid immunization elicited epitope-speciifc IFN-γ-secreting T cells which could lyse CTL epitope-pulsed splenocytes. Conclusion:A Hepatitis C virus CTL-Th epitopes chimeric DNA vaccine which can induce epitope-speciifc CTL response is successfully constructed.